ENGAGE-501; Phase II study investigating the role of epigenetic therapy with entinostat (SNDX-275) hi relapsed and refractory Hodgkin's lymphoma (HL)

被引：2
|
作者：
Younes, A.
Rosen, P. J.
Hernandez-Ilizaliturri, F. J.
Bociek, G.
Kasamon, Y. L.
Copeland, A.
Lee, G. T.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Tower Canc Res Fdn, Beverly Hills, CA USA
[3] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[4] Univ Nebraska Med Ctr, Omaha, NE USA
[5] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[6] Syndax Pharmaceut Inc, Waltham, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.tps298
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS298
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Preliminary results from a phase II study of lenalidomide monotherapy in Relapsed/Refractory aggressive non-Hodgkin's lymphoma.
    Wiemik, Peter H.
    Lossos, Izidore
    Tuscano, Joseph
    Justice, Glen
    Vose, Julie M.
    Pietronigro, Dennis
    Takeshita, Kenichi
    Ervin-Haynes, Annette
    Zeldis, Jerome B.
    Habermann, Thomas M.
    BLOOD, 2006, 108 (11) : 160A - 161A
  • [42] A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin’s lymphoma
    Young-Woong Won
    Hyewon Lee
    Hyeon-Seok Eom
    Jin Seok Kim
    Cheolwon Suh
    Dok Hyun Yoon
    Jung Yong Hong
    Hye Jin Kang
    Jae Hoon Lee
    Won Seog Kim
    Seok Jin Kim
    Won-Sik Lee
    Myung Hee Chang
    Young Rok Do
    Jun Ho Yi
    Inho Kim
    Jong-Ho Won
    Kyoungha Kim
    Sung Yong Oh
    Jae-Cheol Jo
    Annals of Hematology, 2020, 99 : 255 - 264
  • [43] Early results from a phase II study of lenalidomide monotherapy in relapsed/refractory indolent non-Hodgkin's lymphoma.
    Wilzig, Thomas E.
    Vose, Julie M.
    Kaplan, Henry P.
    Wolf, Jeffrey Lee
    Pietronigro, Dennis
    Takeshita, Kenichi
    Ervin-Haynes, Annette
    Zeldis, Jerome B.
    Wiernik, Peter H.
    BLOOD, 2006, 108 (11) : 703A - 703A
  • [44] Phase II Study of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (02) : 10 - 11
  • [45] EVIDENCE OF CLINICAL ACTIVITY IN A PHASE II STUDY OF ORAL PANOBINOSTAT IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA (HL) AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT (AHSCT)
    Engert, A.
    Sureda, A.
    Chiattone, C.
    Buccheri, V.
    Ong, T. C.
    Ben-Yehuda, D.
    Myke, N.
    Shen, A.
    Le Corre, C.
    Younes, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 473 - 474
  • [46] BIOMARKER ANALYSIS OF PIVOTAL PHASE II STUDY OF ORAL PANOBINOSTAT (PAN) IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA (HL) PATIENTS FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANT (ASCT)
    Harrison, S.
    Hsu, A.
    Neeson, P.
    Younes, A.
    Sureda, A.
    Engert, A.
    Li, M.
    Savage, P.
    Bugarini, R.
    Le Corre, C.
    Williams, D.
    Gallagher, J.
    Shen, A.
    Prince, H. M.
    Ritchie, D.
    ANNALS OF ONCOLOGY, 2011, 22 : 138 - 138
  • [47] Phase II study of weekly low-dose paclitaxel for relapsed and refractory non-Hodgkin's lymphoma: A Wisconsin Oncology Network study
    Kahl, BS
    Bailey, HH
    Smith, EP
    Turman, N
    Smith, J
    Werndli, J
    Williams, EC
    Longo, WL
    Kim, KM
    McGovern, J
    Jumonville, A
    CANCER INVESTIGATION, 2005, 23 (01) : 13 - 18
  • [48] Interim results for the phase II study of panobinostat (LBH589) in patients (Pts) with relapsed/refractory Hodgkin's lymphoma (HL) after autologous hematopoietic stem cell transplant (AHSCT)
    Sureda, A.
    Engert, A.
    Browett, P. J.
    Radford, J. A.
    Verhoef, G. E.
    Ramchandren, R.
    Myke, N.
    Shen, A.
    Le Corre, C.
    Younes, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [49] Multicenter phase II clinical study of iodine-131-rituximab radioimmunotherapy in relapsed or refractory indolent non-Hodgkin's lymphoma
    Leahy, Michael F.
    Seymour, John F.
    Hicks, Rodney J.
    Turner, J. Harvey
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (27) : 4418 - 4425
  • [50] Combination phase I/II study of irinotecan hydrochloride (CPT-11) and carboplatin in relapsed or refractory non-Hodgkin's lymphoma
    Tobinai, K
    Hotta, T
    Saito, H
    Ohnishi, K
    Ohno, R
    Ogura, M
    Ariyoshi, Y
    Takeyama, K
    Kobayashi, T
    Ohashi, Y
    Shirakawa, S
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1996, 26 (06) : 455 - 460
12345